We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock
FRTX

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

60 hedge funds and large institutions have $32.8M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

5,100% more call options, than puts

Call options by funds: $104K | Put options by funds: $2K

33% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 12

6% less funds holding

Funds holding: 64 → 60 (-4)

8% less capital invested

Capital invested by funds: $35.7M → $32.8M (-$2.89M)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
60
Holders Change
-4
Holders Change %
-6.25%
% of All Funds
1.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
16
Reduced
12
Closed
6
Calls
$104K
Puts
$2K
Net Calls
+$102K
Net Calls Change
-$36K

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$835K
2
Renaissance Technologies
Renaissance Technologies
New York
+$586K
3
AI
Ariel Investments
Illinois
+$483K
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$237K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$131K

Top Sellers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
-$1.29M
2
TC
TFS Capital
Pennsylvania
-$243K
3
Millennium Management
Millennium Management
New York
-$134K
4
Two Sigma Investments
Two Sigma Investments
New York
-$99.2K
5
Goldman Sachs
Goldman Sachs
New York
-$86.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
51
Guggenheim Capital
Illinois
$10K – – –
MA
52
MUFG Americas
New York
$8K +$3.2K +1 +50%
First Manhattan
53
First Manhattan
New York
$6K – – –
Morgan Stanley
54
Morgan Stanley
New York
$6K +$3.2K +1 +100%
PAM
55
Panagora Asset Management
Massachusetts
$5K – – –
Bank of America
56
Bank of America
North Carolina
$5K +$3.2K +1 +100%
AIG
57
American International Group
New York
$3.78K – – –
LTFS
58
Ladenburg Thalmann Financial Services
Florida
$2K – – –
Simplex Trading
59
Simplex Trading
Illinois
$2K +$3.2K +1 New
TWA
60
TCI Wealth Advisors
Arizona
$2K +$3.2K +1 New
FWM
61
Focused Wealth Management
New York
$1K – – –
FAM
62
Formidable Asset Management
Ohio
$1K – – –
TC
63
TFS Capital
Pennsylvania
– -$243K -73 Closed
CCM
64
Coldstream Capital Management
Washington
– -$57K -17 Closed
OAM
65
Oxford Asset Management
United Kingdom
– -$24K -7 Closed
Citadel Advisors
66
Citadel Advisors
Florida
– -$17K -5 Closed
RCM
67
Rotella Capital Management
Washington
– -$16K -5 Closed
Group One Trading
68
Group One Trading
Illinois
– -$6.4K -2 Closed
1 2
3

FRTX Hedge Fund Activity: Q1 2015 in Review

60 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q1 2015, worth a combined $32.8M — down 8.1% from $35.7M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of FRTX and 2 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 16 added.

The largest buyer was RA Capital Management, adding an estimated $835K. The largest seller was Great Point Partners, cutting an estimated $1.29M.

  • 60 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q1 2015, down from 64 in Q4 2014.
  • Funds reported $32.8M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q1 2015, down 8.1% quarter-over-quarter.
  • 2 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q1 2015 and 6 closed out, a net change of -4 holders.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q1 2015 was RA Capital Management, an estimated $835K added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q1 2015 was Great Point Partners, an estimated $1.29M sold.

Based on aggregated 13F filings for Q1 2015.